Sterol 14alpha-Demethylase (CYP51) as a Therapeutic Target for Human Trypanosomiasis and Leishmaniasis

E-ISSN： 1873-4294|11|16|2060-2071

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.11, Iss.16, 2011-08, pp. : 2060-2071

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Target-Based Drug Discovery for Malaria, Leishmaniasis, and Trypanosomiasis

Current Medicinal Chemistry, Vol. 7, Iss. 8, 2000-08 ,pp. : 835-860

Bentham Science Publishers

Access to resources Recommend Favorite

Lysine-specific demethylase 1 as a potential therapeutic target

By Stavropoulos Pete Hoelz André

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 6, 2007-06 ,pp. : 809-820

Informa Healthcare

Access to resources Recommend Favorite

Developments in the treatment of leishmaniasis and trypanosomiasis

By Olliaro Piero Lazdins Janis Guhl Felipe

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 1, 2002-05 ,pp. : 61-67

Informa Healthcare

Access to resources Recommend Favorite

New Strategies and Paradigm for Drug Target Discovery: A Special Focus on Infectious Diseases Tuberculosis, Malaria, Leishmaniasis, Trypanosomiasis and Gastritis

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 13, Iss. 5, 2013-10 ,pp. : 352-364

Bentham Science Publishers

Access to resources Recommend Favorite

Classical QSAR Study on Chromene Derivatives as Lanosterol 14 -Demethylase Inhibitor: A Non Azole Antifungal Target

Medicinal Chemistry, Vol. 2, Iss. 4, 2006-07 ,pp. : 363-367

Bentham Science Publishers

Access to resources Recommend Favorite